Evidence map›Paper›PMID 28965496›Full record

ArticleInfection control and hospital epidemiology2017

Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?

Pranita D Tamma, Ruibin Wang, Shawna Lewis, Belita N A Opene, Patricia J Simner

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection control and hospital epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pranita D Tamma1Division of Infectious Diseases Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore,Maryland.
Ruibin Wang2Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
Shawna Lewis3Department of Pathology,Johns Hopkins University School of Medicine,Baltimore,Maryland.
Belita N A Opene3Department of Pathology,Johns Hopkins University School of Medicine,Baltimore,Maryland.
Patricia J Simner3Department of Pathology,Johns Hopkins University School of Medicine,Baltimore,Maryland.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

The Use of MALDI TOF for the Rapid Detection of Carbapenemases from Clinical IsolatesK23AI127935 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TAMMA, PRANITA · 2017 to 2020
$734k
Real-Time Whole Genome Sequencing Analysis of Carbapenemase-Producing Organisms in the Non-Outbreak Hospital SettingR21AI130608 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SIMNER, PATRICIA · 2017 to 2018
$449k
NIAID NIH HHS K23 AI127935NIAID NIH HHS R21 AI130608
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Academic Medical CentersAcinetobacterAcinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsCenters for Disease Control and Prevention, U.S.Drug Resistance, MicrobialHumansImipenemMarylandMeropenemMicrobial Sensitivity TestsPseudomonasAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsImipenemMeropenemThienamycins

Identifiers

PMID28965496
PMCPMC5748885
OpenAlexW2758327142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.